Position in NAGE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,860,197
+$46,407 QoQ
Shares Held
1,328,843
+45.4% QoQ
Ownership
1.67%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. NAGE ranks #75 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in NAGE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,860,197 | 1,328,843 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,813,790 | 914,118 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,652,290 | 713,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,055,136 | 489,600 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,609,390 | 523,100 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,784,904 | 712,788 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,548,330 | 424,200 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,135,953 | 416,100 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,335,276 | 383,700 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $671,101 | 469,302 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $649,571 | 444,912 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $723,046 | 460,539 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $653,616 | 427,200 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $959,112 | 570,900 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $760,398 | 618,210 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,235,633 | 739,900 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,034,432 | 420,501 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $142,449 | 38,088 | Shares | Sole | 2022-02-11 | |
| 2020-12-31 | $1,128,960 | 235,200 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $326,337 | 81,381 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $964,818 | 210,200 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||